...
首页> 外文期刊>Annals of allergy, asthma, and immunology >Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way? American College of Allergy, Asthma, & Immunology effects/therapeutic use
【24h】

Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way? American College of Allergy, Asthma, & Immunology effects/therapeutic use

机译:非处方的鼻内皮质类固醇:赋予患者权力或以伤害他人的方式?美国过敏,哮喘和免疫学影响/治疗用途

获取原文
获取原文并翻译 | 示例

摘要

Patients with rhinitis have a myriad of confusing choices they are presented with at their local pharmacy, department, or grocery store: oral and topical decongestants, antihistamines, nasal cromolyn, mucolytics, saline sprays, and combination agents, to name a few. Soon, the Food and Drug Administration (FDA) will be considering adding yet another therapeutic class for over-the-counter use: topical nasal corticosteroids.
机译:鼻炎患者在当地药房,部门或杂货店有很多令人困惑的选择:口服和局部减充血药,抗组胺药,鼻腔克罗莫林,粘液溶解剂,盐水喷雾剂和联合用药,仅举几例。不久,美国食品药品监督管理局(FDA)将考虑添加另一种非处方使用的治疗药物:局部用鼻皮质类固醇激素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号